<DOC>
	<DOCNO>NCT02448121</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy autologous bone marrow stem cell sickle cell disease patient hip osteonecrosis</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cell Transplantation Hip Osteonecrosis Sickle Cell Disease</brief_title>
	<detailed_description>The aim study evaluate autologous bone marrow stem cell transplantation safe potentially beneficial treatment sickle cell disease patient hip osteonecrosis .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<criteria>Stable sickle cell disease patient FICAT classification osteonecrosis , inclusive Stage II . Diagnosis base XRay magnetic resonance imaging ( MRI ) . No infection affect bone time surgery . Patient competent give inform consent . Scoring least 20 point pain daily life activity questionnaire . FICAT stage III Patients history corticosteroid active therapy Bone infection limb affect necrosis Recurrent painful crisis , Immunosuppressive drug therapy , Pregnancy , Presence neoplastic disease clinical concurrent condition sickle cell disease predispose development osteonecrosis femoral head</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cell therapy</keyword>
	<keyword>Sickle cell disease</keyword>
	<keyword>Hip Osteonecrosis</keyword>
	<keyword>Autologous implantation</keyword>
	<keyword>Mesenchymal stromal cell</keyword>
</DOC>